Reporter brief
The Efficacy and Safety of a Mental Intervention Program vs. Usual Care and Nicotinamide Riboside (NR) vs. Placebo for Improving Health-related Quality of Life in Long Covid: A 2 x 2 Factorial Randomized Controlled Trial
What happened
Trial registry update: COMPLETED. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- The study protocol describes planned methodology but provides no results, so no efficacy of NR or MBRT can be determined from this text
- The 2x2 factorial design allows comparison of NR versus placebo and MBRT versus usual care, but the text does not report whether either intervention improved quality of life or secondary outcomes
- The explorative objectives including subgroup effects, mediators, and predictors are listed as planned analyses but no findings are presented
Study design and sample
Rct; Human.
Individuals (18-70 years) with confirmed Long COVID interfering negatively with daily activities
- Design
- Rct
- Sample
- 310
- Journal
- University Hospital, Akershus
- Published
- Aug 25, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Nicotinamide riboside timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.